Mark Smedley, global head of operations at Invitrogen, will lead the integration team that will prepare the company’s merger with Applied Biosystems. Prior to joining Invitrogen, he was with Novartis, where he led and helped with several global multi-business, multi-billion dollar integrations.


Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.